In contrast, it has been reported that GPR65 expression enhances tumor growth in Lewis lung carcinoma cells [5,29], and that GPR65 is overexpressed in glioblastoma, which is associated with an unfavorable clinical outcome for patients [30]. This evidence concerns the gene GPR65 and glioblastoma.